{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T21:10:06Z","timestamp":1747775406518,"version":"3.41.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T00:00:00Z","timestamp":1426032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00280-015-2719-6","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T03:51:49Z","timestamp":1425959509000},"page":"961-968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of cyclosporine A on the hepatobiliary disposition and hepatic uptake of etoposide in an isolated perfused rat liver model"],"prefix":"10.1007","volume":"75","author":[{"given":"Mina","family":"Khezrian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behjat","family":"Sheikholeslami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Dadashzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda","family":"Lavasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadreza","family":"Rouini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,11]]},"reference":[{"key":"2719_CR1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-409X(02)00173-4","volume":"55","author":"KN Faber","year":"2003","unstructured":"Faber KN, Muller M, Jansen PL (2003) Drug transporter proteins in the liver. Adv Drug Deliv Rev 55:107\u2013124. doi: 10.1016\/S0169-409X(02)00173-4","journal-title":"Adv Drug Deliv Rev"},{"key":"2719_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-3659(01)00480-1","volume":"78","author":"H Kusuhara","year":"2002","unstructured":"Kusuhara H, Sugiyama Y (2002) Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. J Control Release 78:43\u201354. doi: 10.1016\/S0168-3659(01)00480-1","journal-title":"J Control Release"},{"key":"2719_CR3","first-page":"237","volume":"1775","author":"JP Gillet","year":"2007","unstructured":"Gillet JP, Efferth T, Remacle J (2007) Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochem Biophys 1775:237\u2013262. doi: 10.1016\/j.bbcan.2007.05.002","journal-title":"Biochem Biophys"},{"key":"2719_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","volume":"55","author":"AH Schinkel","year":"2003","unstructured":"Schinkel AH, Jonker JW (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55:3\u201329. doi: 10.1016\/S0169-409X(02)00169-2","journal-title":"Adv Drug Deliv Rev"},{"key":"2719_CR5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00003088-198712040-00001","volume":"12","author":"PI Clark","year":"1987","unstructured":"Clark PI, Slevin ML (1987) The clinical pharmacology of etoposide and teniposide. Clin Pharmacokinet 12:223\u2013252. doi: 10.2165\/00003088-198712040-00001","journal-title":"Clin Pharmacokinet"},{"key":"2719_CR6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/1097-0142(19910101)67:1+<319::AID-CNCR2820671319>3.0.CO;2-D","volume":"67","author":"ML Slevin","year":"1991","unstructured":"Slevin ML (1991) The clinical pharmacology of etoposide. Cancer 67:319\u2013329. doi: 10.1002\/1097-0142(19910101)67:1+<319:AID-CNCR2820671319>3.0.CO;2-D","journal-title":"Cancer"},{"key":"2719_CR7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1078-0432.CCR-09-1321","volume":"16","author":"LS Jurien","year":"2010","unstructured":"Jurien LS, Fan L, Wagenaar E, Vlaming ML, van Tellingen O, Beijnen JH, Schinkel AH (2010) P-glycoprotein, Abbc2 and Abcc3 determine the pharmacokinetic of etoposide. Clin Cancer Res 16:130\u2013140. doi: 10.1158\/1078-0432.CCR-09-1321","journal-title":"Clin Cancer Res"},{"key":"2719_CR8","first-page":"1339","volume":"63","author":"JD Allen","year":"2003","unstructured":"Allen JD, van Dort SC, Buitelaar M, van Tellingen O, Schinkel AH (2003) Mouse breast cancer resistance protein (Bcrp1\/Abcg2) mediated etoposide resistance and transport, but etoposide oral availability is limited primarily by p-glycoprotein. Cancer Res 63:1339\u20131344","journal-title":"Cancer Res"},{"key":"2719_CR9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/sj.leu.2402455","volume":"16","author":"NJ Lacayo","year":"2002","unstructured":"Lacayo NJ, Lum BL, Becton DL, Weinstein H, Ravindranath Y, Chang MN et al (2002) Pharmacokinetic interaction of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukaemia. Lukemia 16:920\u2013927. doi: 10.1038\/sj\/leu\/2402455","journal-title":"Lukemia"},{"key":"2719_CR10","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/bjc.1998.383","volume":"77","author":"G Bisogno","year":"1997","unstructured":"Bisogno G, Cowie F, Boddy A, Thomas HD, Dick G, Pinkerton CR (1997) High dose cyclosporine with etoposide toxicity and pharmacokinetic interaction in children with solid tumours. Br J Cancer 77:2304\u20132309. doi: 10.1038\/bjc.1998.383","journal-title":"Br J Cancer"},{"key":"2719_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/1056-8719(94)90024-8","volume":"31","author":"JA Hnadler","year":"1994","unstructured":"Hnadler JA, Kossor DC, Goldstein RS (1994) Assessment of hepatobiliary functions in vivo and ex vivo in the rat. J Pharmacol Toxicol Methods 31:11\u201319. doi: 10.1016\/1056-8719(94)90024-8","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2719_CR12","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1080\/10826076.2011.585483","volume":"34","author":"R Saadati","year":"2011","unstructured":"Saadati R, Dadashzadeh S (2011) Simple and efficient HPLC-UV quantitation of etoposide and its cis-isomer in rat micro-volume plasma and tissue sample: application to pharmacokinetic and biodistribution studies. J Liq Chromatogr Relat Technol 34:2130\u20132148. doi: 10.1080\/10826076.2011.585483","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"2719_CR13","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1992.10.10.1624","volume":"10","author":"AM Yahanda","year":"1992","unstructured":"Yahanda AM, Alder KM, Fisher GA, Brophy NA, Halsey J, Hardy RI, Gosland MP, Lum BL, Sikic BI (1992) Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance. J Clin Oncol 10:1624\u20131634","journal-title":"J Clin Oncol"},{"key":"2719_CR14","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.1992.10.10.1635","volume":"10","author":"BL Lum","year":"1992","unstructured":"Lum BL, Kaubisch S, Yahanda AM, Adler KM, Jew L, Ehsan MN, Brophy NA, Halsey J, Gosland MP, Sikic BI (1992) Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. J Clin Oncol 10:1635\u20131642","journal-title":"J Clin Oncol"},{"key":"2719_CR15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-3565(24)37880-2","volume":"287","author":"DE Burgio","year":"1998","unstructured":"Burgio DE, Gosland MP, McNamara PJ (1998) Effects of P-glycoprotein modulators on etoposide elimination and central nervous system distribution. J Pharmacol Exp Ther 287:911\u2013917","journal-title":"J Pharmacol Exp Ther"},{"key":"2719_CR16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/bdd.606","volume":"29","author":"MR Rouini","year":"2008","unstructured":"Rouini MR, Ghazi-Khansari M, Ardakani YH, Dasian Z, Lavasani H (2008) A disposition kinetic study of tramadol in rat perfused liver. Biopharm Drug Dispos 29:231\u2013235. doi: 10.1002\/bdd.606","journal-title":"Biopharm Drug Dispos"},{"key":"2719_CR17","first-page":"47","volume":"7","author":"R Mehvar","year":"2004","unstructured":"Mehvar R, Chimalakonda AP (2004) Hepatic disposition of cyclosporine A in isolated perfused rat livers. J Pharm Pharm Sci 7:47\u201354","journal-title":"J Pharm Pharm Sci"},{"key":"2719_CR18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jps.21831","volume":"99","author":"R Parasrampuria","year":"2010","unstructured":"Parasrampuria R, Mehvar R (2010) Effect of P-glycoprotein and MRP2 inhibitors on the hepatobiliary disposition of rhodamine 123 and its glucuronidated metabolite in isolated perfused rat livers. J Pharm Sci 99:455\u2013466. doi: 10.1002\/jps.21831","journal-title":"J Pharm Sci"},{"key":"2719_CR19","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1002\/jps.22187","volume":"99","author":"R Parasrampuria","year":"2010","unstructured":"Parasrampuria R, Mehvar R (2010) Dose-dependent inhibition of transporter-mediated hepatic uptake and biliary excretion of methotrexate by cyclosporine A in an isolated perfused rat liver model. J Pharm Sci 99:5060\u20135069. doi: 10.1002\/jps.22187","journal-title":"J Pharm Sci"},{"key":"2719_CR20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/00498250500136676","volume":"35","author":"M Yamazaki","year":"2005","unstructured":"Yamazaki M, Li B, Louie SW, Pudvah NT, Stocco R, Wongb W et al (2005) Effect of fibrate on human organic anion-transporting polypeptide 1B1, multidrug resistance protein 2 and P-glycoprotein mediated transport. Xenobiotica 35:737\u2013753. doi: 10.1080\/00498250500136676","journal-title":"Xenobiotica"},{"key":"2719_CR21","doi-asserted-by":"crossref","first-page":"46400","DOI":"10.1074\/jbc.M107041200","volume":"276","author":"N Zelcer","year":"2001","unstructured":"Zelcer N, Saeki T, Reid G, Beijnen JH, Borst P (2001) Characterization of drug transport by the human multidrug resistance protein 3(ABCC3). J Biol Chem 276:46400\u201346407. doi: 10.1074\/jbc.M107041200","journal-title":"J Biol Chem"},{"key":"2719_CR22","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1073\/pnas.96.12.6914","volume":"96","author":"M Kool","year":"1999","unstructured":"Kool M, van der Linden M, de Haas M, Scheffer GL, de Vree JM, Smith AJ et al (1999) MRP3 an organic anion transporter able to transport anti-cancer drug. Proc Natl Acad Sci USA 96:6914\u20136919","journal-title":"Proc Natl Acad Sci USA"},{"key":"2719_CR23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2010.03722.x","volume":"70","author":"DG Balley","year":"2010","unstructured":"Balley DG (2010) Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br J Clin Pharmacol 70:645\u2013655. doi: 10.1073\/pnas.96.12.6914","journal-title":"Br J Clin Pharmacol"},{"key":"2719_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-5793(93)80403-H","volume":"333","author":"M Bohme","year":"1993","unstructured":"Bohme M, Buchler M, Muller M, Keppler D (1993) Differential inhibition by cyclosporins of primary-active ATP-dependent transporters in the hepatocyte canalicular membrane. FEBS Lett 333:193\u2013196. doi: 10.1016\/0014-5793(93)80403-H","journal-title":"FEBS Lett"},{"key":"2719_CR25","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1124\/dmd.108.025544","volume":"37","author":"Y Shitar","year":"2009","unstructured":"Shitar Y, Nagamatsu Y, Wada S, Sugiyama Y, Horie T (2009) Long lasting inhibition of transporter mediated hepatic uptake of sulfobromophthalein by cyclosporine A in rats. Drug Metab Dispos 37:1172\u20131178. doi: 10.1124\/dmd.108.025544","journal-title":"Drug Metab Dispos"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-015-2719-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-015-2719-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-015-2719-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T20:31:24Z","timestamp":1747773084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-015-2719-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,11]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["2719"],"URL":"https:\/\/doi.org\/10.1007\/s00280-015-2719-6","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2015,3,11]]}}}